Nov 23-26, Nanologica will take part of the Biotechgate Digital Partnering event. This is a virtual business development event during four days with the aim of partnering and establishing new global connections. The Biotechgate Digital Partnering is designed to support the business development of Biotech, Medtech and Pharma companies through pre-booked one-on-one meetings.
Nov 18-19 marks the kick off and take off dates for the newly formed Sweden Inhalation Networks. The network is constituted of a small group of scientists with a particular interest in inhaled medicines, that have explored the opportunity to form a Swedish cross disciplinary network. The aim for the network is to maintain and further grow the world class inhalation competence in Sweden. The main targets is to facilitate sharing of inhalation science and
Nov 17, Nanologica will take part of the exclusive Swedish-US networking event Hidden Gems of the Swedish Drug Discovery & Development Pipeline. The aim of the event is to bring together a selection of Swedish and Californian companies active in this field, ranging from small highly innovative companies to big pharma and biotech. Organisers include the US Embassy in Sweden, the Swedish Embassy in the US, AmCham, SACC & BIOCOM. The Swedish and Californian drug
Nanologica presenterar på Spotlight Nexts bolagsdag den 12 november kl 15.15. Följ eventet via länken nedan
November 10 at 10.15, Nanologica will participate at Redeye R&D Tools Seminar. The event can be live streamed on redeye.se. In this seminar, Redeye invites companies that provide tools & supplies for the biopharma industry and academia. An investment in this segment can offer exposure to strong underlying trends in the pharma industry, without necessarily taking binary bets. In recent years, some of the top performers within the life science sector belong to this segment,
The section for Surface and Materials Chemistry at the Swedish Chemical Society organizes The Annual Surface and Materials Chemistry Symposium, this year held on 21 – 22 October 2020. CTO of Nanologica, Prof. Adam Feiler, will during the symposium give a presentation on Development of porous silica particles for drug delivery. The symposium may be followed on Zoom after registration on https://asmcs.se/. Prof. Adam Feiler will present at 16.20 on Oct 21.
